Inactive Instrument

DiNonA Inc.

A086080

KR7086080009

DiNonA Inc. announced that it has received KRW 18 billion in funding from S-MAC CO., Ltd.

February 27, 2018

On February 28, 2018, DiNonA Inc. (XKON:A086080) closed the transaction.

Latest news about DiNonA Inc.

An unknown buyer agreed to acquire approximately 16.5% stake in DiNonA Inc. from Kumho HT, Inc for KRW 19.9 billion.	21-11-02	CI
Kumho HT, Inc. completed the acquisition of remaining 81% stake in DiNonA Inc..	21-10-26	CI
Samsung Biologics Inks Development Partnership with Dinona for Potential COVID-19 Treatment	20-10-20	CI
DiNonA Inc. completed the acquisition of 9.25% stake in Hwail Pharmaceutical Co.,Ltd. from Park, Pil Joon.	20-09-29	CI
Hwail Pharmaceutical Co.,Ltd. announced that it has received KRW 20.02 billion in funding from DiNonA Inc.	20-09-28	CI
DiNonA Inc. agree to acquire 9.25% stake in Hwail Pharmaceutical Co.,Ltd. from Park, Pil Joon for KRW 30.8 billion	20-09-16	CI
Kumho HT, Inc. agreed to acquire remaining 81% stake in DiNonA Inc. for approximately KRW 170 billion.	20-08-26	CI
DiNonA Inc. announced that it has received KRW 19.999996625 billion in funding	20-07-30	CI
Hwail Pharmaceutical Co.,Ltd. announced that it expects to receive KRW 20.02 billion in funding from DiNonA Inc.	20-07-29	CI
DiNonA Inc. announced that it expects to receive KRW 39.999995596 billion in funding from Korea Fixed-Income Investment Advisory, Midasdong-a Investment Co.,Ltd., S-MAC CO., Ltd., Kumho HT, Inc.	20-07-07	CI
DiNonA Inc. announced that it expects to receive KRW 19.999996625 billion in funding	20-06-30	CI
Lumimicro Co., Ltd cancelled the acquisition of DiNonA Inc..	19-12-17	CI
Lumimicro Co., Ltd agreed to acquire DiNonA Inc. for approximately KRW 130 billion.	19-09-26	CI
DiNonA Inc. has withdrawn its IPO.	18-04-12	CI
DiNonA Inc. announced that it has received KRW 18 billion in funding from S-MAC CO., Ltd.	18-02-27	CI
DiNonA Inc. announced that it expects to receive KRW 18 billion in funding from S-MAC CO., Ltd.	18-02-26	CI
DiNonA Inc. has filed an IPO.	15-04-30	CI
3SBio Inc. Signs Exclusive Patent License Agreement with DiNonA Inc. for Leukotuximab	14-08-07	CI

DiNonA Inc. is a Korea-based company principally engaged in the manufacturing and sale of medical devices. The Company operates its business through two segments. The Medical Devices Business segment manufactures and sells laser medical devices and medical device accessories. The Biopharmaceutical Business segment manufactures and sells diagnostic reagents and research reagents such as pregnancy test kits, antibody for raw materials, and antibody for leukemia treatment.

Sector

Pharmaceuticals

More about the company